Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

TGFBR2

RBC: TGFBR2 · Substrate: MBP ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Ponatinib90.80.53
Vemurafenib86.40.60
Dabrafenib72.60.63
Pacritinib72.20.45
Fedratinib41.10.58
Lenvatinib35.50.73
Erdafitinib32.60.74
Canertinib30.10.67
Pazopanib23.90.67
Lorlatinib20.50.69
Binimetinib19.70.69
Selpercatinib17.20.64
Gilteritinib17.10.51
Pirtobrutinib17.10.66
Dacomitinib16.40.66

Known variants

No variants catalogued.
Open in new tab